Metallothionein-I in the plasma and liver of neonatal rats

The Biochemical Journal
|February 1, 1984
PubMed

Insights

Metallothionein-I protein levels are high in neonatal rat plasma and liver, rapidly decreasing by 32 days of age. This study quantifies metallothionein-I concentrations during early development in rats.

Area of Science:

  • Biochemistry
  • Developmental Biology
  • Toxicology

Background:

  • Metallothionein-I (MT-I) is a crucial protein involved in metal detoxification and cellular protection.
  • Understanding MT-I dynamics during neonatal development is vital for assessing early-life exposures and health outcomes.

Purpose of the Study:

  • To quantify the developmental changes in metallothionein-I concentrations in neonatal rat plasma and liver.
  • To establish baseline levels of MT-I during the critical early postnatal period.

Main Methods:

  • Radioimmunoassay (RIA) was employed to measure metallothionein-I concentrations.
  • Samples were collected from male and female neonatal rats at various time points from birth to 32 days of age.

Main Results:

  • Plasma metallothionein-I concentrations were significantly higher in 4-day-old female rats (740 ng/ml) compared to males (350 ng/ml).
  • Both sexes showed a rapid decline in plasma MT-I to 3.5 ng/ml by 32 days of age.
  • Liver MT-I concentrations were high in newborns (200 µg/g) and began to decrease from 12 days of age.

Conclusions:

  • Neonatal rats exhibit distinct, high levels of metallothionein-I that undergo rapid decline postnatally.
  • Sex-specific differences in plasma MT-I levels are evident in early development.
  • These findings provide critical data on metallothionein-I ontogeny in rats.

Related Concept Videos